Donepezil is named as an intervention in 2 current clinical trials in our China register. 2 are recruiting patients now. All registered phases are Not applicable. The sponsor with the most trials is Jian Pei,MD (1). The most-studied condition is Alzheimer Disease.
| Study | Phase | Status | Lead sponsor | Registers |
|---|---|---|---|---|
|
Clinical Evaluation on the Therapeutic Effect of Acupuncture Treatment for Alzheimer's Disease
NCT03810794 · ClinicalTrials.gov ↗ · Alzheimer Disease, Cognitive Impairment
|
Not applicable | Recruiting | Jian Pei,MD | China |
|
Clinical Evaluation of Acupuncture Treatment on Alzheimer's Disease in APOE e4 Carriers and Non-Carriers
NCT06417086 · ClinicalTrials.gov ↗ · Alzheimer Disease, Cognitive Impairment
|
Not applicable | Recruiting | ZhanYJ | China |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
The same active substance in our other registers, matched by its exact name. Each entry links to the register record it comes from.
16 single-substance products containing Donepezil on the HPRA medicines list.
| Lead sponsor | Trials |
|---|---|
| Jian Pei,MD | 1 |
| ZhanYJ | 1 |
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in China | 2 | 2 |
A trial with sites in more than one country appears in each of those registers.
2 current trials in our China register name Donepezil as a drug or biological intervention, as of the registry sync on 25 September 2026. Completed and withdrawn studies are not counted.
Yes. 2 of the 2 trials are recruiting: 2 with sites in China. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Jian Pei,MD (1) and ZhanYJ (1). The number in brackets is how many trials each organisation leads.
Yes. The HPRA medicines list includes 16 single-substance products containing Donepezil, for example ARICEPT 10 mg film coated tablets (Pfizer Healthcare Ireland Unlimited Company). A licence does not mean a product is currently marketed or reimbursed; see each product's record.
The registers we track list 1 entry for Donepezil: US FDA: resolved. Shortages are product- and country-specific; check with a pharmacist.
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Donepezil works or whether it is effective, and it is not medical advice.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Donepezil works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Donepezil (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 25 Sep 2026.